As data centers race to meet artificial intelligence’s voracious appetite for electricity, two nuclear innovators are locked in a fierce battle royale over who will dominate the clean energy revolution. Oklo (NYSE: OKLO) and NuScale Power (NYSE: SMR) represent contrasting paths to solving the power crisis, each with distinct advantages and challenges.
Reactor Design: Size Matters in the Small Modular Reactor Race
The fundamental difference between these competitors comes down to engineering philosophy. Oklo’s microreactor units generate approximately 15 megawatts of electricity, with larger variants capable of producing 50 MW or 75 MW. NuScale’s design is more substantial, with individual modules delivering 50 MW or 77 MW each.
This size differential has profound strategic implications. Oklo’s smaller architecture offers greater flexibility for customers with moderate power requirements—particularly attractive for facilities seeking reliable, continuous electricity without committing to NuScale’s larger footprint. The design aligns well with distributed energy needs across various industrial and data center applications.
Both companies employ factory-assembled, transportable reactor units—a manufacturing approach that promises cost efficiency and rapid deployment. However, the scalability of Oklo’s modular platform may unlock customer segments that find NuScale’s minimum capacity excessive.
Regulatory Approval and Commercial Progress: The Critical Dividing Line
Here lies the most consequential distinction. NuScale has already secured NRC (Nuclear Regulatory Commission) design certification for its reactor—a regulatory milestone that provides substantial first-mover advantage. This approval represents the government’s formal stamp that the design is technically sound and safe for commercial operation.
Oklo, by contrast, remains navigating the NRC’s licensing pathway, having targeted 2027 for the commencement of commercial operations. This regulatory lag translates into immediate credibility for NuScale, though it masks a deeper reality: neither company has yet deployed a functional reactor for a paying commercial customer.
The regulatory advantage hasn’t translated into revenue generation. NuScale currently produces minimal commercial income, while Oklo reports zero sales. Both organizations are essentially pre-revenue businesses navigating the expensive process of scaling novel nuclear technology.
Business Model and Revenue Diversification: Building for the Future
Oklo has pursued a more aggressive diversification strategy through its acquisition of Atomic Alchemy, a radioisotope company. This expansion into specialized isotope production opens near-term revenue opportunities before the company’s flagship reactors begin commercial deployment. The move signals management’s understanding that the path to profitability requires multiple revenue streams during the lengthy development phase.
NuScale’s commercial strategy remains narrowly focused on reactor deployment, without comparable revenue diversification efforts. The company is burning substantial cash as it awaits its first meaningful commercial contract.
The Market Verdict and Investment Stakes
The market has rendered an initial judgment: Oklo commands a $10 billion market capitalization, while NuScale trades at roughly $4.3 billion—a significant valuation gap despite NuScale’s regulatory advantage. This disconnect suggests investors view Oklo’s technology and business model as possessing greater long-term potential, despite current regulatory setbacks.
Both securities remain speculative, high-risk investments subject to significant volatility. The nuclear sector as a whole carries execution risk, regulatory uncertainty, and capital intensity that could alter outcomes dramatically.
Which Nuclear Stock Offers Greater Long-Term Potential?
For investors contemplating long-term nuclear exposure, this battle royale presents a genuine dilemma. NuScale’s regulatory certification provides nearer-term credibility and reduces certain regulatory risks. Yet Oklo’s technology flexibility, early backing from influential figures like Sam Altman, partnerships with the U.S. Department of Energy, relationships with multiple data center operators, and diversified revenue approach position it for potentially superior long-term growth.
The smaller reactor design may ultimately prove more adaptable to real-world deployment scenarios than larger modular competitors. Early relationships with artificial intelligence infrastructure companies suggest robust future demand.
Before committing capital to either nuclear investment, consider that established investment research organizations have evaluated the broader nuclear sector and identified alternative opportunities they believe merit higher conviction. The historical precedent—instances where early conviction in transformative technology companies produced exceptional returns—demonstrates that identifying the authentic category winner among competing platforms remains exceptionally difficult.
Both stocks will experience considerable near-term turbulence. However, for patient investors believing in nuclear energy’s role powering the AI revolution, Oklo appears positioned as the more compelling long-term growth proposition in this ongoing battle royale.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The Nuclear Industry's Battle Royale: Oklo and NuScale Compete for AI Energy Dominance
As data centers race to meet artificial intelligence’s voracious appetite for electricity, two nuclear innovators are locked in a fierce battle royale over who will dominate the clean energy revolution. Oklo (NYSE: OKLO) and NuScale Power (NYSE: SMR) represent contrasting paths to solving the power crisis, each with distinct advantages and challenges.
Reactor Design: Size Matters in the Small Modular Reactor Race
The fundamental difference between these competitors comes down to engineering philosophy. Oklo’s microreactor units generate approximately 15 megawatts of electricity, with larger variants capable of producing 50 MW or 75 MW. NuScale’s design is more substantial, with individual modules delivering 50 MW or 77 MW each.
This size differential has profound strategic implications. Oklo’s smaller architecture offers greater flexibility for customers with moderate power requirements—particularly attractive for facilities seeking reliable, continuous electricity without committing to NuScale’s larger footprint. The design aligns well with distributed energy needs across various industrial and data center applications.
Both companies employ factory-assembled, transportable reactor units—a manufacturing approach that promises cost efficiency and rapid deployment. However, the scalability of Oklo’s modular platform may unlock customer segments that find NuScale’s minimum capacity excessive.
Regulatory Approval and Commercial Progress: The Critical Dividing Line
Here lies the most consequential distinction. NuScale has already secured NRC (Nuclear Regulatory Commission) design certification for its reactor—a regulatory milestone that provides substantial first-mover advantage. This approval represents the government’s formal stamp that the design is technically sound and safe for commercial operation.
Oklo, by contrast, remains navigating the NRC’s licensing pathway, having targeted 2027 for the commencement of commercial operations. This regulatory lag translates into immediate credibility for NuScale, though it masks a deeper reality: neither company has yet deployed a functional reactor for a paying commercial customer.
The regulatory advantage hasn’t translated into revenue generation. NuScale currently produces minimal commercial income, while Oklo reports zero sales. Both organizations are essentially pre-revenue businesses navigating the expensive process of scaling novel nuclear technology.
Business Model and Revenue Diversification: Building for the Future
Oklo has pursued a more aggressive diversification strategy through its acquisition of Atomic Alchemy, a radioisotope company. This expansion into specialized isotope production opens near-term revenue opportunities before the company’s flagship reactors begin commercial deployment. The move signals management’s understanding that the path to profitability requires multiple revenue streams during the lengthy development phase.
NuScale’s commercial strategy remains narrowly focused on reactor deployment, without comparable revenue diversification efforts. The company is burning substantial cash as it awaits its first meaningful commercial contract.
The Market Verdict and Investment Stakes
The market has rendered an initial judgment: Oklo commands a $10 billion market capitalization, while NuScale trades at roughly $4.3 billion—a significant valuation gap despite NuScale’s regulatory advantage. This disconnect suggests investors view Oklo’s technology and business model as possessing greater long-term potential, despite current regulatory setbacks.
Both securities remain speculative, high-risk investments subject to significant volatility. The nuclear sector as a whole carries execution risk, regulatory uncertainty, and capital intensity that could alter outcomes dramatically.
Which Nuclear Stock Offers Greater Long-Term Potential?
For investors contemplating long-term nuclear exposure, this battle royale presents a genuine dilemma. NuScale’s regulatory certification provides nearer-term credibility and reduces certain regulatory risks. Yet Oklo’s technology flexibility, early backing from influential figures like Sam Altman, partnerships with the U.S. Department of Energy, relationships with multiple data center operators, and diversified revenue approach position it for potentially superior long-term growth.
The smaller reactor design may ultimately prove more adaptable to real-world deployment scenarios than larger modular competitors. Early relationships with artificial intelligence infrastructure companies suggest robust future demand.
Before committing capital to either nuclear investment, consider that established investment research organizations have evaluated the broader nuclear sector and identified alternative opportunities they believe merit higher conviction. The historical precedent—instances where early conviction in transformative technology companies produced exceptional returns—demonstrates that identifying the authentic category winner among competing platforms remains exceptionally difficult.
Both stocks will experience considerable near-term turbulence. However, for patient investors believing in nuclear energy’s role powering the AI revolution, Oklo appears positioned as the more compelling long-term growth proposition in this ongoing battle royale.